A phase 2 randomised, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren’s syndrome

Maria Juarez, Nieves Diaz, Geoffrey Johnston, Saba Nayar, Andrew Payne, Eric Helmer, Dionne Cain, Paulette Williams, Valerie Devauchelle-Pensec, Benjamin Fisher, Roberto Giacomelli, Jacques-Eric Gottenberg, Giuliana Guggino, Marika Kvarnstrom, Xavier Mariette, Wan-Fai Ng, Jose Rosas, Juan Burson, Giovanni Triolo, Francesca BaroneSimon Bowman

Research output: Contribution to journalArticlepeer-review

67 Downloads (Pure)

Fingerprint

Dive into the research topics of 'A phase 2 randomised, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren’s syndrome'. Together they form a unique fingerprint.

Medicine & Life Sciences